Vault-13

Stonepine Capital Management, LLC

Bend, OR · CIK 1440771 · 13F filing filed 2024-08-21

SEC-registered investment adviser since 2026 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Bend, OR (main office)United States United Statesabout 1
Sausalito, CA2 officesUnited States United States2

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$109.6m reported value -13.1% vs Q1 2024
25positions
87.3%in top 10
12 new 4 added 8 reduced 7 sold out vs Q1 2024

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ADMA BIOLOGICS INC COM ADMA ADMA 1,870,000 $20.9m19.07% 19.07% ReducedShares held: Q3 2023 9.1m, Q4 2023 9.2m, Q1 2024 3.4m, Q2 2024 1.9m -1.6m -1,556,882 -45.4%
2 ALIMERA SCIENCES INC COM NEW ALIM ALIM 3,511,816 $19.5m17.81% 17.81% ReducedShares held: Q3 2023 4.0m, Q4 2023 4.0m, Q1 2024 4.1m, Q2 2024 3.5m -539.3k -539,256 -13.3%
3 EVOLUS INC COM EOLS EOLS 1,657,611 $18.0m16.41% 16.41% ReducedShares held: Q3 2023 5.2m, Q4 2023 5.3m, Q1 2024 2.7m, Q2 2024 1.7m -1.0m -1,016,745 -38.0%
4 GALAPAGOS NV SPON ADR LKFT LKFT 485,000 $12.0m10.97% 10.97% AddedShares held: Q3 2023 802.5k, Q4 2023 261.9k, Q1 2024 393.6k, Q2 2024 485.0k +91.4k +91,366 23.2%
5 REVANCE THERAPEUTICS INC COM RVNC RVNC 2,800,000 $7.2m6.57% 6.57% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 2.0m, Q2 2024 2.8m +823.7k +823,658 41.7%
6 XOMA ROYALTY CORPORATION COM NEW XOMA XOMA 250,129 $5.9m5.41% 5.41% ReducedShares held: Q3 2023 436.6k, Q4 2023 250.0k, Q1 2024 253.8k, Q2 2024 250.1k -3.6k -3,641 -1.4%
7 ANIKA THERAPEUTICS INC COM ANIK ANIK 165,397 $4.2m3.82% 3.82% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 60.9k, Q2 2024 165.4k +104.4k +104,448 171.4%
8 TELA BIO INC COM TELA TELA 625,645 $2.9m2.68% 2.68% ReducedShares held: Q3 2023 491.9k, Q4 2023 317.8k, Q1 2024 688.2k, Q2 2024 625.6k -62.6k -62,555 -9.1%
9 RIGEL PHARMACEUTICALS INC COM RIGL RIGL 305,000 $2.5m2.29% 2.29% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 305.0k
10 OPTINOSE INC COM COM 2,350,010 $2.4m2.23% 2.23% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 2.4m
11 ACLARIS THERAPEUTICS INC COM ACRS ACRS 1,927,446 $2.1m1.93% 1.93% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.9m
12 SCPHARMACEUTICALS INC COM SCPH SCPH 421,703 $1.8m1.67% 1.67% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 446.8k, Q2 2024 421.7k -25.1k -25,073 -5.6%
13 AURINIA PHARMACEUTICALS INC COM AUPH AUPH 300,000 $1.7m1.56% 1.56% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 300.0k
14 MILESTONE PHARMACEUTICALS IN COM MIST MIST 1,239,199 $1.6m1.49% 1.49% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.5m, Q2 2024 1.2m -223.1k -223,097 -15.3%
15 AYTU BIOPHARMA INC COM AYTU AYTU 472,469 $1.4m1.26% 1.26% UnchangedShares held: Q3 2023 472.4k, Q4 2023 472.5k, Q1 2024 472.5k, Q2 2024 472.5k
16 KIORA PHARMACEUTICALS INC COM NEW EYEG EYEG 200,000 $840.0k0.77% 0.77% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 200.0k
17 ADICET BIO INC COM COM 609,446 $737.4k0.67% 0.67% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 141.5k, Q2 2024 609.4k +467.9k +467,898 330.6%
18 SURROZEN INC COM NEW SRZN SRZN 66,084 $723.6k0.66% 0.66% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 66.1k
19 EXAGEN INC COM XGN XGN 358,697 $652.8k0.60% 0.60% ReducedShares held: Q3 2023 1.2m, Q4 2023 669.7k, Q1 2024 384.6k, Q2 2024 358.7k -25.9k -25,903 -6.7%
20 KEZAR LIFE SCIENCES INC COM COM 1,050,452 $630.3k0.58% 0.58% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.1m
21 APREA THERAPEUTICS INC COM NEW APRE APRE 137,174 $558.3k0.51% 0.51% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 137.2k
22 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 100,000 $385.0k0.35% 0.35% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 100.0k
23 ETON PHARMACEUTICALS INC COM ETON ETON 110,000 $361.9k0.33% 0.33% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 110.0k
24 IRONWOOD PHARMACEUTICALS INC COM CL A IRWD IRWD 48,012 $313.0k0.29% 0.29% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 48.0k
25 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 5,000 $81.2k0.07% 0.07% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 5.0k

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
NEKTAR THERAPEUTICS 3,480,409 $3.3m3.5m shares
CALCIMEDICA INC 522,602 $2.2m522.6k shares
RIGEL PHARMACEUTICALS INC 1,040,241 $1.5m1.0m shares
XERIS BIOPHARMA HOLDINGS INC XERS XERS 598,086 $1.3m598.1k shares
REZOLUTE INC RZLT RZLT 121,479 $309.8k121.5k shares
IO BIOTECH INC IOBTQ IOBTQ 156,167 $270.2k156.2k shares
SCYNEXIS INC 95,637 $140.6k95.6k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
QUOIN PHARMACEUTICALS LTD QNRX · 13G · filed 2026-05-15 QNRX 10.0% -0.6 pts 13G 2026-05-15
AEON BIOPHARMA INC AEON · 13G · filed 2026-07-21 AEON 9.9%≈ $3.9m new 13G 2026-07-21
AZITRA INC 13G · filed 2026-06-22 9.9% new 13G 2026-06-22
ELOXX PHARMACEUTICALS INC ELOX · 13G · filed 2026-06-16 ELOX 9.9%≈ $5.6m new 13G 2026-06-16
SINTX TECHNOLOGIES INC SINT · 13G · filed 2026-06-09 SINT 9.9%≈ $1.2m new 13G 2026-06-09
CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-05-15 CNSP 9.9%≈ $760.7k +2.0 pts 13G 2026-05-15
CELLECTAR BIOSCIENCES INC CLRB · 13G · filed 2026-05-11 CLRB 9.9%≈ $2.4m new 13G 2026-05-11
CURIS INC 13G · filed 2026-03-27 9.9%≈ $2.1m new 13G 2026-03-27
IN8BIO INC INAB · 13G · filed 2025-12-22 INAB 9.9%≈ $1.4m new 13G 2025-12-22
AYTU BIOPHARMA INC AYTU · 13G · filed 2025-08-13 AYTU 9.9%≈ $1.9m 13G 2025-08-13
OPTINOSE INC OPTN · 13G · filed 2025-05-14 OPTN 7.8% +1.9 pts 13G 2025-05-14
FEMASYS INC FEMY · 13G · filed 2026-08-31 FEMY 7.2%≈ $2.6m new 13G 2026-08-31
EDESA BIOTECH INC EDSA · 13G · filed 2026-08-26 EDSA 6.9%≈ $5.9m +6.6 pts 13G 2026-08-26
CALCIMEDICA INC 13G · filed 2026-08-25 6.0%≈ $2.2m +1.4 pts 13G 2026-08-25
TELA BIO INC TELA · 13G · filed 2025-02-13 TELA 6.0%≈ $1.8m 13G 2025-02-13
PASITHEA THERAPEUTICS CORP KTTA · 13G · filed 2026-06-23 KTTA 5.8%≈ $1.0m new 13G 2026-06-23